4.7 Article

Glucose-6-Phosphate-Mediated Activation of Liver Glycogen Synthase Plays a Key Role in Hepatic Glycogen Synthesis

期刊

DIABETES
卷 62, 期 12, 页码 4070-4082

出版社

AMER DIABETES ASSOC
DOI: 10.2337/db13-0880

关键词

-

资金

  1. Diabetes UK
  2. British Heart Foundation
  3. British Medical Research Council (MRC)
  4. MRC
  5. Wellcome Trust [093991/Z/10/Z]
  6. National Institutes of Health [R37 DK050277, U24 DK059637]
  7. Ministry of Science and Innovation, Spain [BFU2011-30554]
  8. Autonomous Government of Catalonia [2009SGR-1176]
  9. Fundacion Marcelino Botin
  10. CIBERDEM (Instituto de Salud Carlos III)
  11. AstraZeneca
  12. Boehringer Ingelheim
  13. GlaxoSmithKline
  14. Merck Co. Inc.
  15. Merck KGaA
  16. Pfizer
  17. Wellcome Trust [093991/Z/10/Z] Funding Source: Wellcome Trust
  18. MRC [MC_U127015389] Funding Source: UKRI
  19. British Heart Foundation [PG/09/059/27851] Funding Source: researchfish
  20. Diabetes UK [07/0003529] Funding Source: researchfish
  21. Medical Research Council [MC_U127015389] Funding Source: researchfish

向作者/读者索取更多资源

The liver responds to an increase in blood glucose levels in the postprandial state by uptake of glucose and conversion to glycogen. Liver glycogen synthase (GYS2), a key enzyme in glycogen synthesis, is controlled by a complex interplay between the allosteric activator glucose-6-phosphate (G6P) and reversible phosphorylation through glycogen synthase kinase-3 and the glycogen-associated form of protein phosphatase 1. Here, we initially performed mutagenesis analysis and identified a key residue (Arg(582)) required for activation of GYS2 by G6P. We then used GYS2 Arg(582)Ala knockin (+/R582A) mice in which G6P-mediated GYS2 activation had been profoundly impaired (60-70%), while sparing regulation through reversible phosphorylation. R582A mutant-expressing hepatocytes showed significantly reduced glycogen synthesis with glucose and insulin or glucokinase activator, which resulted in channeling glucose/G6P toward glycolysis and lipid synthesis. GYS2(+/R582A) mice were modestly glucose intolerant and displayed significantly reduced glycogen accumulation with feeding or glucose load in vivo. These data show that G6P-mediated activation of GYS2 plays a key role in controlling glycogen synthesis and hepatic glucose-G6P flux control and thus whole-body glucose homeostasis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据